Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)

Summary

PROBE is an observational multicenter cohort study, consisting of a cross-sectional and a 5-years prospective phase, designed to target the major study objectives, such as testing the comprehensiveness of the Behçet's syndrome Overall Damage Index (BODI) in a wide and ethnically heterogeneous cohort of Behçet's syndrome patients, and investigating how damage assessed by the BODI correlates with other major long-term disease outcomes (5-years mortality and hospitalization rates).

Conditions

• Behçet's Syndrome (BS)

Sponsors & Collaborators

• Hôpital de Hautepierre

  collaborator OTHER

• University of Siena

  collaborator OTHER

• Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

  collaborator UNKNOWN

• Università degli Studi di Ferrara

  collaborator OTHER

• Tabriz University of Medical Sciences

  collaborator OTHER

• University of Bari

  collaborator OTHER

• Cairo University

  collaborator OTHER

• Tehran University of Medical Sciences

  collaborator OTHER

• Ibn Sina University Hospital, Rabat, Morocco

  collaborator OTHER

• Istanbul University

  collaborator OTHER

• Nazarbayev University School of Medicine

  collaborator UNKNOWN

• Aristotle University Of Thessaloniki

  collaborator OTHER

• Mayo Clinic

  collaborator OTHER

• Centro Hospitalar do Porto

  collaborator OTHER

• Centro Hospitalar do Tâmega e Sousa

  collaborator OTHER

• Federal University of São Paulo

  collaborator OTHER

• University of Cagliari

  lead OTHER

Principal Investigators

• Matteo Piga, Medicine and Surgery · University of Cagliari

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-07-23

Primary Completion

2027-12-30

Completion

2027-12-30

Countries

• Italy

Study Locations